Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations

Optimum management of patients with cancer during the COVID-19 pandemic has proved extremely challenging. Patients, clinicians and hospital authorities have had to balance the risks to patients of attending hospital, many of whom are especially vulnerable, with the risks of delaying or modifying can...

書誌詳細
主要な著者:	Brown, JE, Wood, SL, Confavreux, C, Abe, M, Weilbaecher, K, Hadji, P, Johnson, RW, Rhoades, JA, Edwards, CM, Croucher, PI, Juarez, P, El Badri, S, Ariaspinilla, G, D'Oronzo, S, Guise, TA, Van Poznak, C
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2021

類似資料

Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations
著者:: J.E. Brown, 等
出版事項: (2021-08-01)

Metastatic bone disease: Pathogenesis and therapeutic options
著者:: Stella D'Oronzo, 等
出版事項: (2019-04-01)

Tumor-host cell interactions in the bone disease of myeloma.
著者:: Fowler, J, 等
出版事項: (2011)

Targeted RNA-seq signature of breast cancer (BC) circulating tumor cells (CTCs) correlates with the onset of bone-only metastases
著者:: Stella D'oronzo, 等
出版事項: (2021-04-01)

Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
著者:: Marica Gentile, 等
出版事項: (2021-02-01)

Combustion structures: is it a question of relationships?
著者:: Cosimo D’Oronzo
出版事項: (2019-12-01)

Osteoprotegerin and the development of myeloma bone disease
著者:: Croucher, P, 等
出版事項: (2004)

Clinical disorders of bone resorption.
著者:: Russell, G, 等
出版事項: (2001)

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
著者:: Locklin, R, 等
出版事項: (2007)

Myeloma cells can down-regulate release of osteoprotegerin (OPG) from human bone cells - A contributing factor in myeloma bone loss?
著者:: Shipman, C, 等
出版事項: (2002)

Advances in the molecular pharmacology of bone and cancer-related bone diseases
著者:: Edwards, CM, 等
出版事項: (2021)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
著者:: Croucher, P, 等
出版事項: (2003)

Bone marrow adipose tissue and cancer
著者:: Edwards, CM
出版事項: (2020)

Editorial: Cancer and bone metastasis, volume II
著者:: Chandi C. Mandal, 等
出版事項: (2022-07-01)

Metabolism in the tumour-bone microenvironment
著者:: Whitburn, J, 等
出版事項: (2021)

Editorial: Bone cell differentiation in health and disease, volume II
著者:: Chandi C. Mandal, 等
出版事項: (2024-11-01)

Editorial - Cancer and Bone special issue
著者:: Edwards, CM, 等
出版事項: (2022)

The role of bone marrow adipocytes in bone metastasis
著者:: Edwards, C, 等
出版事項: (2016)

#23. Elucidating the role of bone marrow stiffness in estrogen signaling in metastatic breast cancer to the bone
著者:: Logan Northcutt, 等
出版事項: (2024-04-01)

Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
著者:: De Leenheer, E, 等
出版事項: (2004)

Psychotropic drugs and bone
著者:: R.W. Gasser, 等
出版事項: (2024-12-01)

The Role of TGF-β in Bone Metastases
著者:: Trupti Trivedi, 等
出版事項: (2021-11-01)

Morphogens and growth factor signalling in the myeloma bone-lining niche
著者:: Morris, EV, 等
出版事項: (2021)

Bone marrow endothelial cells express the osteoclastogenic factor RANKL and its decoy receptor OPG: Evidence for a role in the development of myeloma bone disease.
著者:: De Leenheer, E, 等
出版事項: (2002)

Cells of the bone marrow microenvironment protect myeloma cells from apoptosis induced by TRAIL but not by agonists of TRAIL death receptors.
著者:: Locklin, R, 等
出版事項: (2005)

Bone marrow adipose tissue: a new player in cancer metastasis to bone
著者:: Morris, E, 等
出版事項: (2016)

A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease.
著者:: Ayati, B, 等
出版事項: (2010)

A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease
著者:: Webb Glenn F, 等
出版事項: (2010-04-01)

Modeling the human bone–tumor niche: reducing and replacing the need for animal data
著者:: Rao, SR, 等
出版事項: (2020)

#17. Evolution of epidemiology of bone metastasis in France: A rising issue
著者:: M Belhassen, 等
出版事項: (2024-04-01)

The Bone Marrow Microenvironment in Multiple Myeloma
著者:: Edwards, C
出版事項: (2010)

#46. cAMP-mediated acid signaling regulates tumor-myeloid-bone cell crosstalk in the bone-tumor microenvironment
著者:: Kaylee O'Donnell, 等
出版事項: (2024-04-01)

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
著者:: Bauer M, 等
出版事項: (2012-06-01)

Bone decalcification to assess programmed cell death ligand 1 expression in bone metastases of non-small cell lung cancers
著者:: Guillaume Pontarollo, 等
出版事項: (2020-04-01)

Genetic models of bone disease using ENU mutagenesis
著者:: Brown, S, 等
出版事項: (2009)

The role of bone marrow adipocytes in bone metastasis
著者:: Emma V. Morris, 等
出版事項: (2016-09-01)

Statins and bone: myth or reality?
著者:: Edwards, C, 等
出版事項: (2001)

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
著者:: Edwards, C, 等
出版事項: (2008)

#50. Investigating the role of EphA2 in breast cancer bone metastasis
著者:: Verra Ngwa, 等
出版事項: (2024-04-01)

Wnt signaling: bone's defense against myeloma.
著者:: Edwards, C
出版事項: (2008)